Treatment

Dry Powder Inhaler clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
This study is testing a new inhaled medicine, LTI-03, for Idiopathic Pulmonary Fibrosis (IPF). It aims to see if LTI-03 is safe, helps with lung scarring, and improves IPF symptoms.
For: Idiopathic Pulmonary Fibrosis (IPF)
United States · Australia · Poland